The canonical molecular changes of AD include the formation of insoluble amyloid beta peptide (Aβ) aggregates and neurofibrillary tangles (NFTs) primed by the hyperphosphorylated tau protein. The gene discussed is MAPT; the disease is Alzheimer disease.